AAM
HAE icon

Advisors Asset Management’s Haemonetics HAE Stock Holding History

Advisors Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
+2,427
New +$156K ﹤0.01% 1181
2021
Q3 		– Sell
-2,208
Closed -$147K – 1478
2021
Q2 		$147K Sell
2,208
-1,322
-37% -$93.5K ﹤0.01% 1249
2021
Q1 		$392K Sell
3,530
-48
-1% -$5.94K 0.01% 1068
2020
Q4 		$425K Sell
3,578
-3,104
-46% -$334K 0.01% 1020
2020
Q3 		$583K Sell
6,682
-4,896
-42% -$428K 0.01% 869
2020
Q2 		$1.04M Sell
11,578
-2,850
-20% -$288K 0.02% 681
2020
Q1 		$1.44M Sell
14,428
-819
-5% -$88.8K 0.03% 515
2019
Q4 		$1.75M Buy
15,247
+240
+2% +$29K 0.03% 569
2019
Q3 		$1.89M Buy
15,007
+2,017
+16% +$256K 0.03% 548
2019
Q2 		$1.56M Buy
12,990
+459
+4% +$45.2K 0.03% 640
2019
Q1 		$1.1M Buy
12,531
+1,960
+19% +$178K 0.02% 756
2018
Q4 		$1.06M Buy
10,571
+4,245
+67% +$446K 0.02% 742
2018
Q3 		$725K Buy
6,326
+5,249
+487% +$543K 0.01% 946
2018
Q2 		$96K Buy
+1,077
New +$90.9K ﹤0.01% 1346

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisors Asset Management's HAE Position: Q2 2026 in Review

Advisors Asset Management opened a new position in Haemonetics (HAE) in Q2 2026: 2,427 shares worth $182K. The stake represents ﹤0.01% of the portfolio and ranks #1181 among its holdings. This is a return to the name: Advisors Asset Management previously reported a position in HAE as recently as Q2 2021.

Advisors Asset Management first reported a position in HAE in Q2 2018 and has held it in 14 quarters since. The position peaked at $1.89M in Q3 2019. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Advisors Asset Management held 2,427 shares of Haemonetics worth $182K as of Q2 2026.
  • Haemonetics was a new Advisors Asset Management position in Q2 2026.
  • Haemonetics made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1181 holding.
  • Advisors Asset Management first reported a position in Haemonetics in Q2 2018 and has held it in 14 quarters since.
  • Advisors Asset Management's Haemonetics position peaked at $1.89M in Q3 2019.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.